标题
Myelodysplastic syndromes: Contemporary review and how we treat
作者
关键词
-
出版物
AMERICAN JOURNAL OF HEMATOLOGY
Volume 91, Issue 1, Pages 76-89
出版商
Wiley
发表日期
2015-11-24
DOI
10.1002/ajh.24253
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
- (2015) B. Kwok et al. BLOOD
- 56 ELTROMBOPAG FOR LOW TO INTERMEDIATE-2 RISK MYELODYSPLASTIC SYNDROME
- (2015) D. Townsley et al. LEUKEMIA RESEARCH
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms
- (2014) Dragan Jevremovic et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients
- (2014) Emnet Wassie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia
- (2014) Aristoteles Giagounidis et al. CANCER
- Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
- (2014) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
- (2014) A Porwit et al. LEUKEMIA
- Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
- (2013) Asmita Mishra et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders
- (2013) F. Damm et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
- (2013) Su Jung Song et al. Cell Stem Cell
- Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia
- (2013) Maria Teresa Voso et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
- (2013) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database
- (2013) Maria Teresa Voso et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
- (2013) F Traina et al. LEUKEMIA
- The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
- (2013) A M Aalbers et al. LEUKEMIA
- Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)
- (2012) Rie Ohba et al. ANNALS OF HEMATOLOGY
- Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification
- (2012) P. Font et al. ANNALS OF HEMATOLOGY
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
- (2012) M. M. Patnaik et al. BLOOD
- Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
- (2012) F. Thol et al. BLOOD
- SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
- (2012) V. Visconte et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics
- (2012) W. Kern et al. HAEMATOLOGICA
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
- (2012) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
- (2012) U Germing et al. LEUKEMIA
- Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
- (2012) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Multi-color CD34+ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia
- (2012) Guilin Tang et al. LEUKEMIA RESEARCH
- Vitamin B12-Responsive Pancytopenia Mimicking Myelodysplastic Syndrome
- (2011) Myungshin Kim et al. ACTA HAEMATOLOGICA
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes
- (2011) Lewis R. Silverman et al. CANCER
- Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors
- (2011) S. Parmentier et al. HAEMATOLOGICA
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
- (2011) Thomas Prébet et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
- (2011) Michael Lübbert et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
- (2011) M M Patnaik et al. LEUKEMIA
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- (2011) R Itzykson et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Use of Erythropoietic Stimulating Agents in Myelodysplastic Syndromes
- (2011) V. Santini ONCOLOGIST
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- The Epidemiology of Myelodysplastic Syndromes
- (2010) Mikkael A. Sekeres HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99
- (2010) Jakob R. Passweg et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
- (2010) M Mallo et al. LEUKEMIA
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification
- (2009) R. P. Hasserjian et al. BLOOD
- Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
- (2009) P. L. Greenberg et al. BLOOD
- High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder
- (2009) C. Preudhomme et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach
- (2009) J. M. Bennett et al. HAEMATOLOGICA
- Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study
- (2009) E. P. Alessandrino et al. HAEMATOLOGICA
- Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial
- (2009) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- Hematological manifestations of copper deficiency: a retrospective review
- (2008) Thorvardur R. Halfdanarson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Severe vitamin B12 deficiency resulting in pancytopenia, splenomegaly and leukoerythroblastosis
- (2008) Thorvardur R. Halfdanarson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy
- (2008) Elaine M. Sloand et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now